Gastric bypass might not have long-term benefits in diabetes

11/28/2012 | New York Times (tiered subscription model), The

Thirty-five percent of type 2 diabetes patients who initially experienced disease remission following gastric bypass surgery redeveloped diabetes within five years, while many patients never attained remission after the procedure, a study in Obesity Surgery found. Surgery appeared to be most effective for type 2 diabetes patients without advanced disease, researchers said.

View Full Article in:

New York Times (tiered subscription model), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX